BRIEF published on 11/13/2026 at 18:10, 6 days 20 hours ago Integrated BioPharma Reports Q3 Loss Amid Revenue Decline Financial Results Revenue Decline Operating Loss Integrated BioPharma Q3 2026
PRESS RELEASE published on 11/13/2026 at 18:05, 6 days 21 hours ago Integrated BioPharma Reports Results for its Quarter Ended September 30, 2026
BRIEF published on 05/08/2026 at 22:35, 6 months 11 days ago Integrated BioPharma Reports Decrease in Quarterly Revenue Financial Results Revenue Decline Net Loss Operating Loss Contract Manufacturing
PRESS RELEASE published on 05/08/2026 at 22:30, 6 months 11 days ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026 Integrated BioPharma, Inc. reports $10.1M revenue for Q1 2026, a 27.3% decrease from Q1 2025. Operating loss of $1.1M in Q1 2026. Financial summary provided Financial Results Revenue Quarterly Report Operating Loss Integrated BioPharma
BRIEF published on 02/11/2026 at 22:35, 9 months 8 days ago Integrated BioPharma Announces Q4 2025 Financial Results Financial Results Revenue Decline Net Loss Operating Loss Customer Dependency
PRESS RELEASE published on 02/11/2026 at 22:30, 9 months 8 days ago Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 Integrated BioPharma, Inc. reports financial results for Q4 2025, showing a $1.3M decrease in revenue and operating loss compared to Q4 2024. Key financial details provided Financial Results Revenue Decrease Operating Loss Integrated BioPharma Quarterly Performance
BRIEF published on 11/10/2025 at 21:55, 1 year ago Integrated BioPharma Reports Financial Results for Q3 2025 Financial Results Net Income Revenue Decline Operating Income Contract Manufacturing
PRESS RELEASE published on 11/10/2025 at 21:50, 1 year ago Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 Integrated BioPharma, Inc. reports financial results for the quarter ended September 30, 2025, with $12.7 million revenue and insights on operating income and net income Financial Results Revenue Net Income Operating Income Integrated BioPharma
BRIEF published on 09/23/2025 at 21:45, 1 year 1 month ago Integrated BioPharma Reports Fiscal Year 2025 Results Financial Results Revenue Growth Net Income Operating Income Contract Manufacturing
PRESS RELEASE published on 09/23/2025 at 21:40, 1 year 1 month ago Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 Integrated BioPharma, Inc. reports 11.8% increase in revenue for Q2 2025. Operating income rises in Q2 & FY 2025. Net loss in Q2 but net income grows for FY 2025 Revenue Increase Net Income Net Loss Operating Income Integrated BioPharma
Published on 11/20/2026 at 14:50, 16 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 hour 6 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 1 hour 36 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 1 hour 36 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 14:57, 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita NV
Published on 11/20/2026 at 14:53, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group PLC
Published on 11/20/2026 at 14:51, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications PLC
Published on 11/19/2026 at 19:00, 20 hours 6 minutes ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 08:30, 1 day 6 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 07:30, 1 day 7 hours ago Gimv invests in SpiraTec, a specialist in automation and digital transformation for the process industry